Publications by authors named "Bernhard Stockmeyer"
Page 1 of 1
Synopsis of recent research by authors named "Bernhard Stockmeyer"
- Bernhard Stockmeyer's recent research focuses on the development of novel targeted immunotherapies for various types of leukemia, particularly stressing the importance of dual-targeting strategies to improve efficacy against cancer cells.
- His studies have explored the utility of bispecific and trispecific antibodies that engage different immune effector mechanisms, such as recruiting natural killer (NK) cells, to enhance the destruction of leukemic cells expressing specific surface antigens like CD19, CD33, and CD89.
- Stockmeyer's findings indicate that these targeted agents, including single-chain Fv triplebodies and bispecific antibody derivatives, offer potent strategies for addressing acute myeloid leukemia (AML) and other myeloid malignancies, showing promising results in recruiting immune cells for effective tumor cell lysis.
